Overview

Novaliq GmbH is a biopharmaceutical company focusing on the development and commercialization of ocular therapeutics based on its proprietary water-free technology. The company aims to advance eye care medicine by providing innovative solutions for significant unmet medical needs. Novaliq's technology platform improves the delivery of drugs to both the front and back of the eye, enhancing drug efficacy and patient safety.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Novaliq GmbH in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.